Vitalaxin Study: Call for Female Fibromyalgia Patients

[Guest guest]

Vitalaxin Study: Call for Female Fibromyalgia Patients

----------------------------------------

The University of Minnesota School of Dentistry, Division of Orofacial Pain

and TMD, is conducting a study to determine the efficacy of the hormone

relaxin for treatment of Fibromyalgia. Women with Fibromyalgia between the

ages of 18-65 are being recruited to participate in a randomized 12-week

clinical trial of relaxin in reducing the symptoms of Fibromyalgia. The

study will be conducted by Dr. Francisco Alencar and will involve a

screening evaluation and four visits. Qualified participants will be

compensated.

For screening, please call Patt Carlson at .